Sean P. Nolan Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Sean P. Nolan.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Sean P. Nolan. Sean P. Nolan is Director in Ventas, Inc. ($VTR) and Director in AQUINOX PHARMACEUTICALS, INC ($AQXP) and President & CEO in AveXis, Inc. ($AVXS) and Director in Taysha Gene Therapies, Inc. ($TSHA).
Latest Insider Trading Transactions of Sean P. Nolan
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AVXS, NLTX, TSHA, VTR
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30 2020 | TSHA | Taysha Gene Therap ... | Nolan Sean P. | Director | Option Exercise | C | 0.00 | 1,470 | 0 | 0 | |
| Sep 30 2020 | TSHA | Taysha Gene Therap ... | Nolan Sean P. | Director | Option Exercise | C | 0.00 | 1,000,000 | 0 | 0 | |
| Sep 30 2020 | TSHA | Taysha Gene Therap ... | Nolan Sean P. | Director | Buy | C | 0.00 | 1,601 | 0 | 1,091,101 | 1.1 M to 1.1 M (+0.15 %) |
| Sep 30 2020 | TSHA | Taysha Gene Therap ... | Nolan Sean P. | Director | Buy | C | 0.00 | 1,089,500 | 0 | 1,089,500 | 0 to 1.1 M |
| Sep 25 2020 | TSHA | Taysha Gene Therap ... | Nolan Sean P. | Director | Option Exercise | A | 20.00 | 31,000 | 620,000 | 31,000 | |
| May 20 2020 | VTR | Ventas, Inc. | Nolan Sean P. | Director | Grant | A | 0.00 | 5,424 | 0 | 7,555 | 2.1 K to 7.6 K (+254.53 %) |
| May 20 2020 | VTR | Ventas, Inc. | Nolan Sean P. | Director | Grant | A | 0.00 | 5,424 | 0 | 7,555 | 2.1 K to 7.6 K (+254.53 %) |
| May 07 2020 | NLTX | Neoleukin Therapeu ... | Nolan Sean P. | Director | Option Exercise | A | 12.84 | 25,000 | 321,000 | 25,000 | |
| Oct 15 2019 | AQXP | Neoleukin Therapeu ... | Nolan Sean P. | Director | Option Exercise | A | 2.82 | 22,000 | 62,040 | 22,000 | |
| Oct 15 2019 | AQXP | Neoleukin Therapeu ... | Nolan Sean P. | Director | Option Exercise | A | 2.82 | 22,000 | 62,040 | 22,000 | |
| Jul 29 2019 | VTR | Ventas, Inc. | Nolan Sean P. | Director | Grant | A | 67.03 | 2,131 | 142,841 | 2,131 | 0 to 2.1 K |
| May 15 2018 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Option Exercise | D | 133.80 | 44,000 | 5,887,200 | 0 | |
| May 15 2018 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Option Exercise | D | 77.24 | 96,000 | 7,415,040 | 0 | |
| May 15 2018 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Option Exercise | D | 42.61 | 110,000 | 4,687,100 | 0 | |
| May 15 2018 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Option Exercise | D | 15.94 | 728,300 | 11,609,102 | 0 | |
| May 15 2018 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Sell | D | 0.00 | 11,000 | 0 | 0 | 11 K to 0 (-100.00 %) |
| May 09 2018 | AQXP | AQUINOX PHARMACEUT ... | Nolan Sean P. | Director | Option Exercise | A | 13.10 | 15,000 | 196,500 | 15,000 | |
| Mar 27 2018 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Option Exercise | A | 133.80 | 44,000 | 5,887,200 | 44,000 | |
| Mar 27 2018 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Grant | A | 0.00 | 11,000 | 0 | 11,000 | 0 to 11 K |
| Mar 09 2018 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Option Exercise | M | 15.94 | 10,000 | 159,400 | 728,300 | |
| Mar 09 2018 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Sell | S | 131.86 | 1,100 | 145,046 | 0 | 1.1 K to 0 (-100.00 %) |
| Mar 09 2018 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Sell | S | 130.78 | 600 | 78,468 | 1,100 | 1.7 K to 1.1 K (-35.29 %) |
| Mar 09 2018 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Sell | S | 129.66 | 4,800 | 622,368 | 1,700 | 6.5 K to 1.7 K (-73.85 %) |
| Mar 09 2018 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Sell | S | 128.65 | 2,400 | 308,760 | 6,500 | 8.9 K to 6.5 K (-26.97 %) |
| Mar 09 2018 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Sell | S | 127.65 | 700 | 89,355 | 8,900 | 9.6 K to 8.9 K (-7.29 %) |
| Mar 09 2018 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Sell | S | 126.65 | 400 | 50,660 | 9,600 | 10 K to 9.6 K (-4.00 %) |
| Mar 09 2018 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Buy | M | 15.94 | 10,000 | 159,400 | 10,000 | 0 to 10 K |
| May 12 2017 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Option Exercise | A | 77.24 | 96,000 | 7,415,040 | 96,000 | |
| May 10 2017 | AQXP | AQUINOX PHARMACEUT ... | Nolan Sean P. | Director | Option Exercise | A | 13.74 | 9,000 | 123,660 | 9,000 | |
| Jun 22 2016 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Option Exercise | A | 42.61 | 110,000 | 4,687,100 | 110,000 | |
| May 11 2016 | AQXP | AQUINOX PHARMACEUT ... | Nolan Sean P. | Director | Option Exercise | A | 7.73 | 7,500 | 57,975 | 7,500 | |
| Mar 16 2015 | AQXP | AQUINOX PHARMACEUT ... | Nolan Sean P. | Director | Option Exercise | A | 12.03 | 10,000 | 120,300 | 10,000 |
Page: 1